These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1924647)
1. What is learned during opiate withdrawal conditioning? Evidence for a cue avoidance model. Mucha RF Psychopharmacology (Berl); 1991; 104(3):391-6. PubMed ID: 1924647 [TBL] [Abstract][Full Text] [Related]
2. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Stinus L; Cador M; Zorrilla EP; Koob GF Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444 [TBL] [Abstract][Full Text] [Related]
3. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. McDonald RV; Parker LA; Siegel S Pharmacol Biochem Behav; 1997 Dec; 58(4):1003-8. PubMed ID: 9408206 [TBL] [Abstract][Full Text] [Related]
4. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Kosten TA Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117 [TBL] [Abstract][Full Text] [Related]
5. Effects of contextual or olfactory cues previously paired with morphine withdrawal on behavior and pain sensitivity in the rat. McNally GP; Akil H Psychopharmacology (Berl); 2001 Aug; 156(4):381-7. PubMed ID: 11498714 [TBL] [Abstract][Full Text] [Related]
6. Withdrawal-like effects of pentylenetetrazol and valproate in the naive organism: a model of motivation produced by opiate withdrawal? Mucha RF; Fassos FF; Perl FM Drug Alcohol Depend; 1995 Jul; 39(1):1-6. PubMed ID: 7587968 [TBL] [Abstract][Full Text] [Related]
7. Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine. Parker LA; Joshi A Pharmacol Biochem Behav; 1998 Nov; 61(3):331-3. PubMed ID: 9768568 [TBL] [Abstract][Full Text] [Related]
8. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal. Higgins GA; Nguyen P; Joharchi N; Sellers EM Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177 [TBL] [Abstract][Full Text] [Related]
9. Naloxone-precipitated conditioned taste aversions in morphine-dependent Fischer (F344) and Lewis rat strains. Stephens MK; Riley AL Pharmacol Biochem Behav; 2009 Mar; 92(1):60-7. PubMed ID: 19000706 [TBL] [Abstract][Full Text] [Related]
10. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Higgins GA; Sellers EM Pharmacol Biochem Behav; 1994 May; 48(1):1-8. PubMed ID: 8029278 [TBL] [Abstract][Full Text] [Related]
11. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Mucha RF Brain Res; 1987 Aug; 418(2):214-20. PubMed ID: 3676713 [TBL] [Abstract][Full Text] [Related]
12. Withdrawal from chronic nicotine fails to produce a conditioned taste aversion to saccharin in rats. Villanueva HF; Arezo S; James JR; Rosecrans JA Pharmacol Biochem Behav; 1990 Sep; 37(1):59-61. PubMed ID: 2263667 [TBL] [Abstract][Full Text] [Related]
13. Opiate withdrawal: the result of conditioning or physiological mechanisms? Zellner DA; Dacanay RJ; Riley AL Pharmacol Biochem Behav; 1984 Feb; 20(2):175-80. PubMed ID: 6538972 [TBL] [Abstract][Full Text] [Related]
14. Extinction of conditioned opiate withdrawal in rats is blocked by intracerebroventricular infusion of an NMDA receptor antagonist. Coleman BR; Carlezon WA; Myers KM Neurosci Lett; 2013 Apr; 541():39-42. PubMed ID: 23416323 [TBL] [Abstract][Full Text] [Related]
15. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats. Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507 [TBL] [Abstract][Full Text] [Related]
16. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Azar MR; Jones BC; Schulteis G Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156 [TBL] [Abstract][Full Text] [Related]